Consecutive Seven Serious Cases with Invasive Group A Streptococcal Infections at December 2022-January 2023
- PMID: 36854121
- DOI: 10.1097/INF.0000000000003895
Consecutive Seven Serious Cases with Invasive Group A Streptococcal Infections at December 2022-January 2023
References
-
- Guy R, Henderson KL, Coelho J, et al. Increase in invasive group A streptococcal infection notifications, England, 2022. Euro Surveill. 2023;28:2200942.
-
- de Gier B, Marchal N, de Beer-Schuurman I, et al.; ISIS-AR Study Group. ISIS-AR Study Group; GAS Study group; de Melker HE, van Sorge NM; Members of the GAS study group; Members of the ISIS-AR study group. Increase in invasive group A streptococcal (Streptococcus pyogenes) infections (iGAS) in young children in the Netherlands, 2022. Euro Surveill. 2023;28:2200941.
-
- van Kempen EB, Bruijning-Verhagen PCJ, Borensztajn D, et al. Increase In Invasive Group A Streptococcal Infections In Children In The Netherlands, A Survey Among 7 Hospitals In 2022. Pediatr Infect Dis J. 2022. doi:10.1097/INF.0000000000003810. - DOI
-
- Boeddha NP, Atkins L, de Groot R, et al.; EUCLIDS consortium. EUCLIDS consortium. Group A streptococcal disease in paediatric inpatients: a European perspective. Eur J Pediatr. 2023;182:697–706.
-
- Carapetis JR, Jacoby P, Carville K, et al. Effectiveness of clindamycin and intravenous immunoglobulin, and risk of disease in contacts, in invasive group a streptococcal infections. Clin Infect Dis. 2014;59:358–365.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
